Forest Investigative Site 103 — Canton, Georgia

Forest Investigative Site 103 is a clinical research site located in Canton, Georgia, United States 30114.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forest Investigative Site 103 has participated in 1 clinical trials.

Therapeutic areas: COPD, COPD Exacerbation, Lung Diseases.

Sponsors: AstraZeneca.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Canton

Browse all research sites in Georgia · View every site in Canton

• Northside Hospital, Inc.-Georgia Cancer Specialists
• Northside Hospital,228 Riverstone Dr.
• Northside Hospital, Inc - GCS/Canton
• Northside Hospital-Cherokee
• Research Site
• Medical Associates of North Georgia
• East Coast Institute for Research - Canton
• East Coast Institute for Research
• East Coast Research
• Forest Investigative Site 1828
• Vertex Investigational Site
• Clinical Trial Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forest Investigative Site 103?

Forest Investigative Site 103 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forest Investigative Site 103 conducted?

Forest Investigative Site 103 has 1 clinical trials on record. Their work covers COPD, COPD Exacerbation, Lung Diseases.

Is Forest Investigative Site 103 accredited by Crixeo Clinical Trials?

Forest Investigative Site 103 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forest Investigative Site 103?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.